Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

898.95
+13.751.55%
Pre-market: 857.00-41.9500-4.67%09:07 EDT
Volume:4.37M
Turnover:3.92B
Market Cap:852.19B
PE:76.77
High:902.50
Open:888.20
Low:882.12
Close:885.20
Loading ...
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 30, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 07, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Jan 27, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2023

Correspondence

Form CORRESP - Correspondence
Nov 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 27, 2023

Correspondence

Form CORRESP - Correspondence